Inito

Inito

Private
Bangalore, KarnatakaHealthcare & Life Scienceshttps://www.inito.com

Last Round

Series B

Dec 11, 2025

Total Funding Raised

$35.78M

Momentum Score

25 /100

Company Overview

Inito is a medical technology company that develops at-home diagnostic testing devices. Its flagship product, the Inito Fertility Monitor, is a device that connects to a smartphone and uses test strips to measure key fertility hormones (Estrogen, Luteinizing Hormone, and Progesterone) in urine, allowing users to track their ovulation cycles and receive personalized health analytics through a mobile app. Founded in 2015, the company aims to make healthcare more accessible by providing lab-grade diagnostic tools for home use. After years of research and development, Inito launched globally in mid-2021 and has since raised significant venture capital, including a $6 million Series A round in 2023, to fund global expansion and R&D for new tests covering areas like pregnancy health and male fertility. The company is a graduate of the Y Combinator accelerator program.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, Health IoT, Healthcare Analytics

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

fertility trackerat-home fertility monitorhormone trackingovulation confirmationfemtechPdG testingquantitative hormone measurementovulation trackingTTCsmartphone diagnosticsdirect-to-consumerDTCrazor and blades modelPCOSUS FDA clearanceovulation predictor kitOPKhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inito Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Inito Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BDec 11, 2025
Series ANov 16, 2023
SeedMar 1, 2019
AngelMay 31, 2018

Key People

Founding team and executive leadership

Varun AV

Cofounder And CTO

Founding Team

Aayush Rai

Co-Founder CEO

Founding Team

Inito Investors

Notable investors and investment history

InvestorRounds
Fireside VenturesSeries A, Series B
Y CombinatorSeries B, Seed
Rathi VenturesAngel
Bertelsmann India InvestmentsSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2026

    Launched the InSight Wireless Reader, a Wi-Fi enabled fertility hormone reader.

  • Dec 11, 2025

    $29M round raised

Inito Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inito Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inito's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore, Karnataka
Employee Range237
Year Founded2015
Last FundingDec 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.